US Medical Device Manufacturers Association (MDMA) briefs court on 510(k) process
This article was originally published in Clinica
The US Medical Device Manufacturers Association has gone to court to ensure that judges understand the 510(k) process. The US Court of Appeals considered, in Reeves v AcroMed, that a "not substantially equivalent" finding was substantive evidence that a device was unsafe in a product liability action.
You may also be interested in...
Lannett will launch a further seven products in fiscal 2021, after launching four products recently in the first quarter of FY21. The company also plans to pay off its Term Loan ‘A’ in full, by the end of November 2020.
Pfizer has now received a formal European Commission approval for its Nyvepria biosimilar pegfilgrastim. The approval puts the firm in direct competition with several other versions of the Neulasta original.
AstraZeneca's research head admits that the half dose approach was a lucky mistake – but one that could boost the vaccine's effectiveness and supplies. The US regulator may not be persuaded, however.